Company / Revenue
Co-Diagnostics, Inc. Revenue History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$622.5K
FY2025
5-year range
$622.5K / $97.9M
FY2021-FY2025
Trend
-84.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue has declined for 3 consecutive years, from $98M in FY2022 to $622,489 in FY2025.
Based on SEC 10-K filings.
$622,489 in FY2025 with a 5-year CAGR of +23.7%.
Declined from $7M to $622,489 over the past 2 years.
Revenue over time
Growth rates
- 3-Year CAGR
- -81.5%
- 5-Year CAGR
- +23.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- Co-Diagnostics, Inc.'s revenue has declined for 3 consecutive years.
- 5-year CAGR of +23.7%, indicating consistent growth.
- In FY2025, revenue decreased 84.1% year-over-year.
- Peak revenue was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -6.63 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $622.5K | -84.1% |
| FY2024 | $3.9M | -42.5% |
| FY2023 | $6.8M | -93.0% |
| FY2022 | $97.9M | +31.3% |
| FY2021 | $74.6M | +34579.9% |
| FY2020 | $215.0K | +438.6% |
| FY2019 | $39.9K | +420.9% |
| FY2018 | $7.7K | +0.0% |
| FY2017 | $7.7K | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026